2024 AGM and Scientific Conference
33rd Annual General Meetings and Scientific Conference This year the Ophthalmological Society of Ghana (OSG) will hold its 33rd Annual…
Category: news
Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study
Imoro Zeba Braimah ,Ernest Kenu ,Kwesi N. Amissah-Arthur ,Stephen Akafo ,Kwaku Oppong Kwarteng ,Winfried M. Amoaku| Published: October 24, 2019…
Cardiovascular disease implicated in rapid glaucoma progression
To further understand the systemic and ocular risk factors for rapid glaucoma progression, investigators examined a cohort of rapid and…
Should we image all patients with third nerve palsy?
This retrospective, population-based study assessed the incidence and etiologies of acquired third nerve palsy among newly diagnosed patients. Study design…
Discovery of new angiogenic factor may enhance treatment for retinal disease
Scientists from Massachusetts Eye and Ear have identified a new transcription factor involved in retinal neovascularization: Runt-related transcription factor 1…
Low-cost ziv-aflibercept appears safe for intraocular administration
A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent,…
Telemedicine screening confirms acute ROP is typically symmetrical
In this secondary analysis of the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) study, investigators examined the intereye agreement of…
Early findings hint at safety, efficacy of stem-cell therapy for keratoconus
The growing field of autologous stem-cell therapy has set its sights on another potential ocular target: corneal dystrophies. A Spanish…
Timing of IOL repositioning surgery significantly impacts refractive outcomes
This large retrospective study analyzed the incidence and appropriate timing of repositioning surgery to correct misalignment of toric IOLs. Study…
Injected mitomycin C offers advantages over standard application
This multicenter, randomized clinical trial compared 2 methods for applying mitomycin C (MMC) in eyes undergoing trabeculectomy. Study design Investigators…
Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study
Imoro Zeba Braimah ,Ernest Kenu ,Kwesi N. Amissah-Arthur ,Stephen Akafo ,Kwaku Oppong Kwarteng ,Winfried M. Amoaku| Published: October 24, 2019…
Cardiovascular disease implicated in rapid glaucoma progression
To further understand the systemic and ocular risk factors for rapid glaucoma progression, investigators examined a cohort of rapid and…
Should we image all patients with third nerve palsy?
This retrospective, population-based study assessed the incidence and etiologies of acquired third nerve palsy among newly diagnosed patients. Study design…
Discovery of new angiogenic factor may enhance treatment for retinal disease
Scientists from Massachusetts Eye and Ear have identified a new transcription factor involved in retinal neovascularization: Runt-related transcription factor 1…
Low-cost ziv-aflibercept appears safe for intraocular administration
A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent,…
Telemedicine screening confirms acute ROP is typically symmetrical
In this secondary analysis of the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) study, investigators examined the intereye agreement of…
Early findings hint at safety, efficacy of stem-cell therapy for keratoconus
The growing field of autologous stem-cell therapy has set its sights on another potential ocular target: corneal dystrophies. A Spanish…
Timing of IOL repositioning surgery significantly impacts refractive outcomes
This large retrospective study analyzed the incidence and appropriate timing of repositioning surgery to correct misalignment of toric IOLs. Study…
Injected mitomycin C offers advantages over standard application
This multicenter, randomized clinical trial compared 2 methods for applying mitomycin C (MMC) in eyes undergoing trabeculectomy. Study design Investigators…